Inmaculada Doña Selected Research

Drug Hypersensitivity (Drug Allergy)

1/2022	Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.
1/2021	Multiepitope Dendrimeric Antigen-Silica Particle Composites as Nano-Based Platforms for Specific Recognition of IgEs.
1/2021	Genetic Variants in Cytosolic Phospholipase A2 Associated With Nonsteroidal Anti-Inflammatory Drug-Induced Acute Urticaria/Angioedema.
1/2021	Food-dependent NSAID-induced hypersensitivity (FDNIH) reactions: Unraveling the clinical features and risk factors.
1/2021	Single-dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non-immediate reactions to beta-lactams.
1/2020	Platelet-Adherent Leukocytes Associated With Cutaneous Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs.
1/2020	Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved.
1/2020	Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.
1/2019	Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugs.
1/2019	Identification of Novel Biomarkers for Drug Hypersensitivity After Sequencing of the Promoter Area in 16 Genes of the Vitamin D Pathway and the High-Affinity IgE Receptor.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Inmaculada Doña Research Topics

Disease

38	Hypersensitivity (Allergy) 01/2022 - 11/2009
18	Drug Hypersensitivity (Drug Allergy) 01/2022 - 11/2009
15	Urticaria (Hives) 01/2021 - 11/2013
14	Angioedema 01/2021 - 11/2013
12	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2016
5	Exanthema (Rash) 01/2021 - 07/2012
4	Asthma (Bronchial Asthma) 01/2021 - 01/2013
4	Aspirin-Induced Asthma 01/2021 - 07/2015
3	Infections 01/2022 - 06/2017
3	COVID-19 01/2022 - 11/2020
3	Drug-Related Side Effects and Adverse Reactions 01/2021 - 01/2019
3	Immediate Hypersensitivity 10/2016 - 02/2010
3	Rhinitis 01/2016 - 11/2009
2	Pain (Aches) 01/2020 - 01/2014
2	Allergic Rhinitis 01/2019 - 11/2009
1	Convalescence 01/2022
1	Hereditary Angioedemas 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Chronic Urticaria 01/2021
1	Inflammation (Inflammations) 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 09/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2016
1	Contact Dermatitis (Eczema, Contact) 09/2013
1	Occupational Asthma 01/2013
1	Food Hypersensitivity (Food Allergy) 07/2012
1	Multiple Sclerosis 07/2012

Drug/Important Bio-Agent (IBA)

22	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 11/2009
13	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
10	Immunoglobulin E (IgE)IBA 01/2021 - 11/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 06/2017
4	beta-LactamsIBA 01/2021 - 08/2017
4	Arachidonic Acid (Vitamin F)IBA 01/2021 - 07/2015
4	QuinolonesIBA 01/2020 - 07/2017
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
3	EnzymesIBA 01/2021 - 01/2012
3	AllergensIBA 01/2021 - 11/2009
2	VaccinesIBA 01/2022 - 01/2022
2	BNT162 VaccineIBA 01/2022 - 01/2022
2	COVID-19 VaccinesIBA 01/2022 - 01/2022
2	PyrazolonesIBA 01/2021 - 01/2016
2	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2021 - 02/2010
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021 - 01/2021
2	Moxifloxacin (Avelox)FDA Link 01/2020 - 01/2013
2	Penicillins (Penicillin)FDA Link 01/2020 - 10/2016
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2017 - 01/2012
2	Amoxicillin (Wymox)FDA LinkGeneric 10/2016 - 01/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2016 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2013
1	Excipients (Suspending Agents)IBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Cefazolin (Ancef)FDA LinkGeneric 12/2021
1	A 19IBA 01/2021
1	Kallikreins (Kallikrein)IBA 01/2021
1	LactamsIBA 01/2021
1	Phospholipases A2 (Phospholipase A2)IBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Arthropod VenomsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	IntegrinsIBA 01/2020
1	Contrast MediaIBA 01/2020
1	Cyclooxygenase 1IBA 01/2020
1	LeukotrienesIBA 01/2019
1	ProstaglandinsIBA 01/2019
1	EicosanoidsIBA 01/2019
1	IgE Receptors (Fc epsilon RI)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Omeprazole (Prilosec)FDA LinkGeneric 09/2018
1	Proton Pump InhibitorsIBA 09/2018
1	Neuromuscular Blocking AgentsIBA 08/2017
1	Metronidazole (Metric)FDA LinkGeneric 07/2017
1	SulfonamidesIBA 07/2017
1	Clindamycin (Cleocin)FDA LinkGeneric 07/2017
1	MacrolidesIBA 07/2017
1	Tryptases (Tryptase)IBA 01/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2016
1	Thymic Stromal LymphopoietinIBA 01/2016
1	Dipyrone (Metamizole)IBA 01/2016
1	Histamine Receptors (Histamine Receptor)IBA 11/2013
1	BromidesIBA 09/2013
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2013
1	Toll-Like Receptor AgonistsIBA 01/2013
1	Glatiramer Acetate (Copaxone)FDA Link 07/2012
1	Amine Oxidase (Copper-Containing)IBA 01/2012
1	Infliximab (Remicade)FDA Link 12/2011
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 02/2010

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2018
1	Injections 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Off-Label Use 11/2020